Northstar Asset Management Cut Celgene (CELG) Stake by $966,680; Shares Declined; As Equinix (EQIX) Valuation Declined, Gagnon Securities Has Lowered by $456,171 Its Position

May 27, 2018 - By Stephen Andrade

Equinix, Inc. (NASDAQ:REIT) Logo

Gagnon Securities Llc decreased its stake in Equinix Inc (EQIX) by 5.3% based on its latest 2017Q4 regulatory filing with the SEC. Gagnon Securities Llc sold 1,007 shares as the company’s stock declined 8.22% with the market. The institutional investor held 17,978 shares of the consumer services company at the end of 2017Q4, valued at $8.15 million, down from 18,985 at the end of the previous reported quarter. Gagnon Securities Llc who had been investing in Equinix Inc for a number of months, seems to be less bullish one the $30.83 billion market cap company. The stock increased 0.27% or $1.05 during the last trading session, reaching $388.05. About 332,179 shares traded. Equinix, Inc. (NASDAQ:EQIX) has risen 6.74% since May 27, 2017 and is uptrending. It has underperformed by 4.81% the S&P500.

Northstar Asset Management Llc decreased its stake in Celgene Corporation (CELG) by 43.8% based on its latest 2017Q4 regulatory filing with the SEC. Northstar Asset Management Llc sold 9,295 shares as the company’s stock declined 19.30% with the market. The institutional investor held 11,925 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.25 million, down from 21,220 at the end of the previous reported quarter. Northstar Asset Management Llc who had been investing in Celgene Corporation for a number of months, seems to be less bullish one the $57.11 billion market cap company. The stock decreased 1.14% or $0.91 during the last trading session, reaching $78.63. About 4.78M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 27, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Is Celgene’s Stock A Buy The Dip Opportunity?” on May 23, 2018, also Seekingalpha.com with their article: “Goldman bearish on Celgene” published on May 25, 2018, Finance.Yahoo.com published: “Celgene Corporation: How to Effectively Buy Into CELG Stock” on May 22, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Seekingalpha.com and their article: “Celgene’s (CELG) Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “Celgene: Still (Looks) Appealing” with publication date: May 21, 2018.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 149 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Argus Research given on Wednesday, May 23. The company was downgraded on Wednesday, June 1 by BTIG Research. The rating was maintained by BMO Capital Markets with “Outperform” on Friday, October 27. The rating was maintained by Cowen & Co with “Buy” on Thursday, October 26. Credit Suisse maintained Celgene Corporation (NASDAQ:CELG) on Wednesday, February 28 with “Outperform” rating. The company was maintained on Tuesday, June 6 by Canaccord Genuity. Stifel Nicolaus initiated the stock with “Buy” rating in Friday, July 15 report. Oppenheimer maintained Celgene Corporation (NASDAQ:CELG) on Thursday, July 6 with “Buy” rating. The rating was initiated by Jefferies on Wednesday, September 9 with “Buy”. The rating was downgraded by Standpoint Research to “Hold” on Wednesday, November 9.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36 billion for 10.51 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Since February 8, 2018, it had 2 insider purchases, and 3 insider sales for $3.48 million activity. The insider MARIO ERNEST sold $1.26M. Shares for $851,093 were sold by LOUGHLIN JAMES J on Monday, March 12. Alles Mark J had bought 1,208 shares worth $99,784 on Tuesday, May 8.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Sib Ltd Company owns 3.41% invested in Celgene Corporation (NASDAQ:CELG) for 45,477 shares. Peoples Ser holds 0% or 80 shares. 819,032 are owned by Fifth Third Bank & Trust. Rafferty Asset Management Ltd Limited Liability Company owns 13,582 shares. Davis reported 2.44% in Celgene Corporation (NASDAQ:CELG). 14,050 were reported by Global X Mgmt Limited. Tarbox Family Office has 0.05% invested in Celgene Corporation (NASDAQ:CELG). First Light Asset Mngmt Ltd Liability has invested 0.39% in Celgene Corporation (NASDAQ:CELG). Moreover, Aperio Gp Ltd has 0.25% invested in Celgene Corporation (NASDAQ:CELG). Kbc Gp Nv holds 455,802 shares. Signature Est & Investment Advsr Limited Liability Corp reported 0.01% in Celgene Corporation (NASDAQ:CELG). 4,600 are owned by Tributary Cap Mngmt. Hbk Sorce Advisory Lc has 0.18% invested in Celgene Corporation (NASDAQ:CELG). Shell Asset has invested 0.15% in Celgene Corporation (NASDAQ:CELG). Headinvest reported 22,630 shares stake.

Investors sentiment decreased to 1.33 in 2017 Q4. Its down 0.07, from 1.4 in 2017Q3. It turned negative, as 33 investors sold EQIX shares while 156 reduced holdings. 66 funds opened positions while 185 raised stakes. 74.06 million shares or 1.05% more from 73.29 million shares in 2017Q3 were reported. Massachusetts-based Putnam Investments Limited Liability Corp has invested 0.17% in Equinix, Inc. (NASDAQ:REIT). Gsa Limited Liability Partnership, United Kingdom-based fund reported 2,112 shares. Willingdon Wealth Mngmt reported 3 shares stake. Lpl Fin Lc invested in 4,933 shares. Agf Invs, Ontario – Canada-based fund reported 86,910 shares. The Rhode Island-based Washington has invested 0.55% in Equinix, Inc. (NASDAQ:REIT). Rainier Inv Mngmt stated it has 9,850 shares. Riverpark Advsr Ltd Liability Corp has 9,930 shares. 137 were reported by Tradewinds Cap Limited Liability. Ifc Fl reported 0.04% in Equinix, Inc. (NASDAQ:REIT). 30,171 were accumulated by American Gp Inc. Moore Cap LP accumulated 175,000 shares or 1.44% of the stock. Next Century Growth Ltd Limited Liability Company owns 1,606 shares or 0.09% of their US portfolio. Chase Inv Counsel Corporation stated it has 1.69% in Equinix, Inc. (NASDAQ:REIT). Jane Street Gru Lc has 500 shares.

Since December 14, 2017, it had 0 buys, and 32 selling transactions for $32.22 million activity. Shares for $703,395 were sold by VAN CAMP PETER. $2.07M worth of stock was sold by LYONS IRVING F III on Tuesday, March 6. $657,640 worth of stock was sold by TAYLOR KEITH D on Friday, January 26. $92,486 worth of Equinix, Inc. (NASDAQ:REIT) shares were sold by Campbell Michael Earl. 5,960 Equinix, Inc. (NASDAQ:REIT) shares with value of $2.40 million were sold by Lee Yau Tat. Shares for $435,490 were sold by STROHMEYER KARL on Tuesday, February 27.

Among 24 analysts covering Equinix (NASDAQ:EQIX), 23 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. Equinix had 70 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Buy” rating by Oppenheimer on Wednesday, August 2. The stock has “Buy” rating by RBC Capital Markets on Sunday, September 17. Barclays Capital maintained Equinix, Inc. (NASDAQ:REIT) on Thursday, August 3 with “Equal-Weight” rating. The stock has “Equal-Weight” rating by Barclays Capital on Thursday, August 18. The firm has “Buy” rating given on Tuesday, October 24 by Deutsche Bank. The stock of Equinix, Inc. (NASDAQ:REIT) has “Outperform” rating given on Thursday, October 29 by RBC Capital Markets. The rating was initiated by Barclays Capital on Monday, March 21 with “Equal-Weight”. The firm earned “Buy” rating on Thursday, February 15 by Guggenheim. SunTrust maintained the stock with “Buy” rating in Thursday, October 12 report. The firm earned “Hold” rating on Tuesday, September 5 by Jefferies.

Gagnon Securities Llc, which manages about $353.18M and $281.80M US Long portfolio, upped its stake in Flexion Therapeutics Inc (NASDAQ:FLXN) by 194,276 shares to 338,607 shares, valued at $8.48M in 2017Q4, according to the filing.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Stephen Andrade

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts